• Strength: 1 mg
• Form: Tablet
• Quantity: 28 tablets per pack
• Active Ingredient: Anastrozole
• Indications: Used in the treatment of hormone receptor-positive breast cancer in postmenopausal women.

 

Packaging:

• Bottle Size: Each bottle typically contains 30 tablets of 1 mg Anastrozole.

 

Storage Conditions:

• General Storage:
  • Temperature: Store at room temperature, 20°C to 25°C (68°F to 77°F).
  • Avoid Moisture: Keep in a dry place, away from moisture.
  • Light Protection: Protect from light.
• Handling:
  • Keep Out of Reach of Children: Ensure that the medication is stored safely out of reach of children.

 

Active Ingredient:

• Anastrozole: A non-steroidal aromatase inhibitor that reduces estrogen levels by blocking the aromatase enzyme, which converts androgens into estrogen

 

Dosage and Formulation:

• Dosage: Each tablet contains 1 mg of Anastrozole.
• Form: Oral tablets.
• Tablet Count: Typically, Santra 1 mg is supplied in a bottle containing 30 tablets.

 

Mechanism of Action:

• Aromatase Inhibition: By inhibiting the aromatase enzyme, Anastrozole reduces estrogen levels, which is crucial for treating estrogen-sensitive breast cancer.

 

Primary Uses:

• Breast Cancer Treatment: Used for the adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women, both in early and advanced stages.
• Post Cycle Therapy (PCT): Utilized by bodybuilders to manage estrogenic side effects during and after anabolic steroid cycles, such as gynecomastia.
• Fertility Treatments: Occasionally used off-label to manage estrogen levels and stimulate ovulation in certain cases.

 

Administration:

• Dosage: The standard dose is 1 mg once daily. The dosage may vary based on individual patient requirements and treatment goals.
• Method: Oral administration. Tablets should be swallowed whole with water and taken at the same time each day to maintain consistent blood levels.

 

Side Effects:

• Common: Hot flashes, joint pain, fatigue, headache, nausea, mood swings, and increased sweating.
• Serious: Osteoporosis (bone thinning), severe allergic reactions, liver enzyme abnormalities, and cardiovascular problems. Regular monitoring of bone density and liver function is recommended.

 

Precautions:

• Bone Health: Long-term use may impact bone density; hence, monitoring and preventive measures for bone health are advised.
• Drug Interactions: May interact with other medications, particularly those affecting liver enzymes or hormone therapies.
• Contraindications: Not suitable for use in premenopausal women or during pregnancy.

 

Pharmacokinetics:

• Absorption: Well absorbed after oral intake.
• Metabolism: Metabolized primarily in the liver.
• Elimination: Excreted mainly through the urine.

 

Contact Information

For further information or queries regarding Santra 1 mg Anastrozole, please contact:

Stamina Pharma
Email: info@staminapharma.com